Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 472301 - 472320 out of 476480 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FD01) trastuzumab | HERCEPTIN 150MG SDV | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | GenentechUSA,Inc. |
| USA | (L01FD01) trastuzumab | HERCEPTIN 150MG SDV | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | GenentechUSA,Inc. |
| USA | (L01FD01) trastuzumab | HERZUMA 150MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01FD01) trastuzumab | HERZUMA 150MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01FD01) trastuzumab | KANJINTI 150MG/VIAL INJ | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AmgenUSA,Inc. |
| USA | (L01FD01) trastuzumab | KANJINTI 150MG/VIAL INJ | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AmgenUSA,Inc. |
| USA | (L01FD01) trastuzumab | OGIVRI 150MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BioconBiologics,Inc. |
| USA | (L01FD01) trastuzumab | OGIVRI 150MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BioconBiologics,Inc. |
| USA | (L01FD01) trastuzumab | OGIVRI 150MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BioconBiologics,Inc. |
| USA | (L01FD01) trastuzumab | OGIVRI 150MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BioconBiologics,Inc. |
| USA | (L01FD01) trastuzumab | ONTRUZANT 150MG/VIL INJ | 150MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | OrganonLLC |
| USA | (L01FD01) trastuzumab | ONTRUZANT 150MG/VIL INJ | 150MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | OrganonLLC |
| USA | (L01FD01) trastuzumab | TRAZIMERA 150MG | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | Pfizer,Inc. |
| USA | (L01FD01) trastuzumab | TRAZIMERA 150MG | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | Pfizer,Inc. |
| USA | (L01FD01) trastuzumab | HERZUMA 420MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01FD01) trastuzumab | HERZUMA 420MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01FD01) trastuzumab | KANJINTI 420MG/VIAL INJ | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AmgenUSA,Inc. |
| USA | (L01FD01) trastuzumab | KANJINTI 420MG/VIAL INJ | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AmgenUSA,Inc. |
| USA | (L01FD01) trastuzumab | OGIVRI 420MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BioconBiologics,Inc. |
| USA | (L01FD01) trastuzumab | OGIVRI 420MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BioconBiologics,Inc. |
Pages
